Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation on Mounjaro is common, manageable, and rarely a reason to stop treatment. Tirzepatide slows gastric emptying as part of how it works, and that slower transit can back things up, particularly in the first few weeks or after a dose increase. If you're dealing with this right now, you're far from alone — and there are practical steps that make a real difference. These are prescription-only medicines requiring clinical assessment; a prescriber can help you weigh up both the benefits and the side effects as part of your care.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people on tirzepatide assume constipation means the medicine isn't agreeing with them, or that they need to drop their dose. That's rarely the case. Mounjaro slows gastric emptying deliberately (it's part of the mechanism that reduces hunger and lowers blood sugar) and the gut simply takes time to adjust to that change. The full side-effect picture for Mounjaro is dominated by gastrointestinal effects in general, not one type specifically; some people get loose stools early, others constipation, and many experience both at different stages.
What the clinical trial data show is that GI side effects are most noticeable in the first four to eight weeks and after each titration step. They tend to ease as your body settles at that dose. So if you're a few days into a new pen and things have slowed down, that pattern is expected. It doesn't mean your gut is broken. It means tirzepatide is working as designed, and your digestive system is catching up.
That said, don't dismiss it as trivial either. Genuine discomfort matters, and left unaddressed, constipation can escalate into harder problems, straining, haemorrhoids, abdominal bloating that affects appetite and comfort. If you want to understand more about why Mounjaro causes constipation and how the mechanism behind it differs from ordinary digestive slowdown, that's worth reading before drawing conclusions about your treatment. Worth taking seriously. Worth acting on early.
The three pillars of managing constipation on Mounjaro are not complicated, but the order matters. Fibre without fluid makes things worse, it bulks stool but draws water to do so, so if you're not drinking enough, constipation can intensify rather than ease.
Start with fluid. Tirzepatide suppresses appetite significantly, and many people on treatment eat and drink less than before without noticing. Aim for around 1.5–2 litres of water across the day, not all at once, steadily from morning. If you take the Wegovy tablet format, the morning routine already builds in a glass of water; Mounjaro users need to be more deliberate about it.
Then fibre. Add it gradually rather than all at once. Sudden large increases in insoluble fibre (wheat bran, raw vegetables) can cause bloating when the gut is already slowed. Soluble fibre (oats, linseeds, cooked vegetables, soft fruit) is gentler and draws water into stool to soften it. The Mounjaro treatment overview covers the dietary changes recommended alongside treatment more broadly.
Movement helps. Even a 20-minute walk after meals encourages peristalsis, the rhythmic muscular contractions that push food along. This is particularly relevant on Mounjaro because appetite suppression can mean people become more sedentary without realising it.
If dietary changes alone aren't enough after a week or so, our detailed guide to managing Mounjaro constipation covers over-the-counter options and practical steps your pharmacist can help you work through. Your prescriber should know if you're using laxatives regularly.
Most constipation on Mounjaro is an inconvenience. Some symptoms should not be waited out.
Get urgent medical help if you have severe stomach pain that doesn't ease, especially if it spreads to your back or comes with vomiting. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known but infrequent side effect of GLP-1 medicines including tirzepatide, the key warning sign is persistent, severe abdominal pain that may radiate to the back. This is distinct from ordinary constipation discomfort, but it's worth knowing so you can tell the difference.
Also seek prompt advice if you have not had a bowel movement for more than a week, if you notice blood in your stool, or if constipation is accompanied by significant abdominal swelling or vomiting. These aren't typical presentations of tirzepatide's GI effects and deserve proper assessment.
You can report any suspected side effect from a medicine, including Mounjaro, through the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk. That reporting genuinely helps regulators track the safety profile of medicines in real-world use.
For more detail on the broader range of gut effects tirzepatide can cause, the evidence on whether Mounjaro causes constipation and how to stop constipation on Mounjaro cover the clinical picture in more depth. Our prescribers at nume discuss side-effect management as a routine part of every consultation, not as an afterthought. If constipation is affecting your quality of life or making you uncertain about continuing treatment, that's exactly the conversation to have before making any changes to your dose. Check your eligibility and speak to our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.